V. V. Chikin. (2020). Guselkumab in the treatment of patients with plaque psoriasis of moderate and severe severity: Efficacy and safety of interleukin-23 blockade. State Scientific Center of Dermatovenereology and Cosmetology.
Chicago Style (17th ed.) CitationV. V. Chikin. Guselkumab in the Treatment of Patients with Plaque Psoriasis of Moderate and Severe Severity: Efficacy and Safety of Interleukin-23 Blockade. State Scientific Center of Dermatovenereology and Cosmetology, 2020.
MLA (9th ed.) CitationV. V. Chikin. Guselkumab in the Treatment of Patients with Plaque Psoriasis of Moderate and Severe Severity: Efficacy and Safety of Interleukin-23 Blockade. State Scientific Center of Dermatovenereology and Cosmetology, 2020.
Warning: These citations may not always be 100% accurate.